Drs. Jack Cush and Drs. Akhil Sood, Antoni Chan, Olga Petryna and Eric Dein, discuss highlights from Day 3 at the ACR21 annual meeting. Abstracts include #1367, #1044, #1444, #1083 and more. @akhilsoodsood @synovialjoints @DrPetryna @ejdein1 https://t.co/5lioAkgg2h https://t.co/YReoAepKw1

• https://bit.ly/31cKV7n

Cardiovascular Disease for TNFi vs JAKi: Dr Jon Giles discusses abstracts #0831and #0958 presented at the ACR21 annual meeting. https://t.co/O90HInaS7z https://t.co/MdHVyxfkaW

• https://bit.ly/3rjmIr3

Watch Now: Drs. Janet Pope, David Liew and Eric Dein discuss TNF data presented at the ACR21 annual meeting, including abstracts #1251, #1442, #1448. ( @Janetbirdope, @drdavidliew, @ejdein1) https://t.co/UHmgmlrIqg https://t.co/0y03TFtJI6

• https://bit.ly/3rfGkwp

IL-35 (blood and urine) is elevated in #SLE pts with nephritis. Small study of 42 SLE pts serum IL-35 had 90% sensitivity & 65% specificity while urine IL-35 had 86.4% sensitivity and 75% specificity to establish the diagnosis of LN https://t.co/pK1rVCQQr9

• https://bit.ly/3D45nVm

New Download Available! AOSD Disease Patterns Over Time https://t.co/IYePF20Nkn https://t.co/fOnc6jUl1b

• https://bit.ly/3FWszXt

Dr. Jack Cush interviews Professor Edward Keystone, MD (University of Toronto) on the origins and science behind the 60/40/20 benchmark and outcomes in rheumatoid arthritis. https://t.co/Ve6zOQPxZJ https://t.co/8RuL2CCsOQ

• https://bit.ly/3D3o4Ze

ICYMI:Food for Thought: "ITIS" Diet for Patients with Rheumatoid Arthritis: Dr. Akhil Sood ( @AkhilSoodMD) discusses abstract #1699 presented at the ACR21 annual meeting. https://t.co/bpQuzDGXCF https://t.co/9e2dYddsIx

• https://bit.ly/3CYNnvx

ICYMI: Data on Existing SLE Medications, Patient Centered Outcomes, and Exercise: Dr. Michelle Petri discusses data on existing SLE medications, patient-centered outcomes and the importance of exercise, presented Monday at the #ACR21 annual meeting. https://t.co/SQOLQRmQtp https://t.co/ZA1uISdGyk

• https://bit.ly/3nXrdWr

ICYMI: Update on Safety, Effectiveness of SARS-CoV-2 vaccines in SLE https://t.co/ihWapOaiNO https://t.co/daoIZtpsHH

• https://bit.ly/3I0VCv1

ICYMI: Drs. Jeffrey Sparks, Greg McDermott and Vanessa Kronzer discuss work in the area of respiratory disease in RA, mucosal paradigm, RA-ILD, bronchiectasis, as well as their experience as virtual attendees at the #ACR21 annual meeting. https://t.co/5BrxeJBWM2 https://t.co/m8CqyJ1L7A

• https://bit.ly/3nUIHmg

RheumNow Podcast - 60/40/20 Interview with Dr. Ed Keystone https://t.co/simAKtsQ7q

• https://bit.ly/3CS0rmw

ICYMI: Uveitis and Prevalence of Psoriasis in axSpA: Dr. Robert Chao ( @doctorRBC) discusses the best SpA abstracts he saw at the #ACR21 annual meeting: abstracts #1324 and #1311. https://t.co/XEJMyvKDnx

• https://bit.ly/3nWx6mE

ICYMI: COVID-19 in Patients with Primary Systemic Vasculitis and Polymyalgia Rheumatica Dr. Bella Mehta ( @bella_mehta) interviews Dr. Sebastian Sattui about abstract #0952 presented at the #ACR21 annual meeting. https://t.co/UN66qOGqRd

• https://bit.ly/3FMqJbA

ICYMI: Does Control of Inflammation Lower Cancer Risk? https://t.co/OBMIdPki7O https://t.co/zV04iAOjAz

• https://bit.ly/3pnTpBp

ICYMI: Multimorbidity, the presence of multiple overlapping chronic comorbid conditions, is increasingly common at first presentation of rheumatoid arthritis (RA), increasing as a person gets older and/or during disease progression. https://t.co/CL2xEyjKmd https://t.co/inoyahbkM9

• https://bit.ly/2ZscSYr